Retrieve all available abstracts of the following 323 articles: HTML format
Single Articles
SRINATH A, Pavlova M, Chandar S, Vasudeva Rao S, et al Knowledge, attitudes and practices of women regarding breast and cervical cancer
screening: a qualitative study in India.
Glob Public Health. 2025;20:2467785. PubMed Abstract available
XU D, Zhao X, Ye D, Huo C, et al A gene-based predictive model for lymph node metastasis in cervical cancer:
superior performance over imaging techniques.
J Transl Med. 2025;23:397. PubMed Abstract available
NGUYEN TB, Vu KD, Cu LTN, Ngoc MHN, et al Socioeconomic inequalities in cervical cancer screening practices in Vietnam: a
decomposition analysis.
BMC Public Health. 2025;25:1253. PubMed Abstract available
MAJIMA T, Matsukawa Y, Funahashi Y, Kajikawa K, et al Urodynamic assessment and proteomic analysis of lower urinary tract dysfunction
following nerve-sparing radical hysterectomy.
Sci Rep. 2025;15:11474. PubMed Abstract available
GUPTA A, Dagar G, Das SK, Chauhan R, et al Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid
biopsy.
Sci Rep. 2025;15:11480. PubMed Abstract available
OSMANI V, Rossiter M, Horner L, Nkurunziza T, et al Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years
with abnormal cytology: a systematic review and meta-analysis.
BMJ Glob Health. 2025;10:e017309. PubMed Abstract available
LIU H, Xu R, Chen J, Wang S, et al Viral integration and fusion transcript characteristics of possibly high-risk HPV
in cervical cancer.
Infect Genet Evol. 2025 Apr 1:105746. doi: 10.1016/j.meegid.2025.105746. PubMed Abstract available
WANG R, Zhang F, Li J, Yang D, et al GATA2 promotes cervical cancer progression under the transcriptional activation
of TRIP4.
Cell Signal. 2025 Apr 1:111778. doi: 10.1016/j.cellsig.2025.111778. PubMed Abstract available
CHNG EAC, Smith HE Barriers to cervical cancer screening and the potential role of HPV selfsampling
in Singapore: A cross-sectional study.
Ann Acad Med Singap. 2025;54:192-194. PubMed
MOUCHERAUD C, Kalande P, Chibaka S, Phiri K, et al Human papillomavirus vaccination in rural Malawi: Identifying factors associated
with vaccine uptake using a community-based household survey.
Hum Vaccin Immunother. 2025;21:2485651. PubMed Abstract available
NASRUDIN N, Sazlina SG, Cheong AT, Lee PY, et al Increasing the Uptake of Breast and Cervical Cancer Screening Via the MAwar
Application: Stakeholder-Driven Web Application Development Study.
JMIR Form Res. 2025;9:e65542. PubMed Abstract available
RETRACTION: Fibronectin Promotes Cervical Cancer Tumorigenesis Through Activating
FAK Signaling Pathway.
J Cell Biochem. 2025;126:e70022. PubMed Abstract available
YAO Y, Tao L, Ma L, Fan Y, et al Etiological Factors and Development of a Predictive Model for Urinary Tract
Infections in Cervical Cancer Patients Undergoing Intensity-Modulated
Radiotherapy.
Infect Drug Resist. 2025;18:1637-1645. PubMed Abstract available
ZHANG L, Xiao M, He XC, Lin YP, et al [Analysis of human papillomavirus subtype distribution and cervical lesion
characteristics in a cancer hospital in Shenzhen City].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:490-494. PubMed Abstract available
LI JH, Liu XX, Tang L, Wang FZ, et al [Health economics evaluation of vaccination strategies for different human
papillomavirus vaccines for 12-year-old female adolescents in China].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:425-432. PubMed Abstract available
SPACEK J, Ndukwe MO, Ubom AEB, Sirak I, et al Urologic Fistulas in Czech Women With Gynaecologic Malignancies.
Cancer Rep (Hoboken). 2025;8:e70134. PubMed Abstract available
VOLPI CR, Giuliano AR, Morais E, Felsher M, et al Shifting HPV-cancer burden: from cervical cancer to oropharyngeal cancer.
Infect Agent Cancer. 2025;20:21. PubMed Abstract available
DU M, Li Y, Fan X, Gao H, et al A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix.
Diagn Pathol. 2025;20:33. PubMed Abstract available
VEERAVAGU T, Hamdiui N, Stein ML, Crutzen R, et al Barriers, facilitators, needs, and preferences in seeking information regarding
cervical cancer prevention programs among Turkish, Moroccan, and Syrian immigrant
women: a scoping review.
BMC Public Health. 2025;25:1242. PubMed Abstract available
DAI W, Liu Y, Jiang X, Xu R, et al The inferred modulation of correlated vaginal microbiota and metabolome by
cervical differentially expressed genes across distinct CIN grades.
BMC Microbiol. 2025;25:189. PubMed Abstract available
RETRACTION: Effect of Minimally Invasive Surgery and Laparotomy on Wound
Infection and Postoperative and Intraoperative Complications in the Management of
Cervical Cancer: A Meta-Analysis.
Int Wound J. 2025;22:e70467. PubMed Abstract available
RETRACTION: Best Practices for Managing Malodorous and Infected Wounds in
Advanced Cervical Cancer.
Int Wound J. 2025;22:e70486. PubMed Abstract available
ROKX C Cervical Cancer.
N Engl J Med. 2025;392:1350-1351. PubMed
HARRIS L Cervical Cancer.
N Engl J Med. 2025;392:1350. PubMed
SUBA EJ Cervical Cancer.
N Engl J Med. 2025;392:1349-1350. PubMed
LEON-MALDONADO L, Cabral A, Pages G, Brown B, et al Barriers and facilitators to a combined strategy of HPV vaccination and cervical
cancer screening among Mexican women.
Hum Vaccin Immunother. 2025;21:2483018. PubMed Abstract available
POLEBOYINA PK, Pasha A, Heena SK, Poleboyina SM, et al Evaluating TGF-beta1 gene expression and promoter polymorphism in cervical cancer
progression.
J Mol Histol. 2025;56:126. PubMed Abstract available
TADESE BK, You X, Ndao T, Tota JE, et al The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A
Systematic Literature Review.
J Med Virol. 2025;97:e70274. PubMed Abstract available
ISHIKAWA M, Nakayama K, Ishibashi T, Yamashita H, et al Outcomes and patterns of recurrence of robot?assisted or laparoscopic radical
hysterectomy in early?stage cervical cancer.
Mol Clin Oncol. 2025;22:43. PubMed Abstract available
WU Z, Deng L, Wu W, Zeng B, et al A novel skeletal muscle quantitative method and deep learning-based sarcopenia
diagnosis for cervical cancer patients treated with radiotherapy.
Med Phys. 2025 Apr 1. doi: 10.1002/mp.17791. PubMed Abstract available
KUE J, Tate JA, Pineiro B, Szalacha LA, et al Cultural and Linguistic Adaptation of an Evidence-Based Tailored Navigation
Intervention to Increase Cancer Screening Uptake Among Southeast Asian Women.
Cancer Control. 2025;32:10732748251329867. PubMed Abstract available
FENG X, Li J, Li C, Wang J, et al SiaQuant Unveils Serum alpha2,3/alpha2,6 Sialylation Heterogeneities and Predicts
Neoadjuvant Chemotherapy Response in Locally Advanced Cervical Cancer.
Anal Chem. 2025 Apr 1. doi: 10.1021/acs.analchem.4c04952. PubMed Abstract available
CONDE-RODRIGUEZ I, Perez-Picazo S, Vazquez-Zamora VJ, Reyes-Leyva J, et al Serum soluble Tim?3 is elevated in patients with cervical cancer and is higher in
advanced clinical stages.
Biomed Rep. 2025;22:90. PubMed Abstract available
HUANG Q, Xu YF, Li HP, Zhang T, et al Bioinformatics and experimental approach reveal potential prognostic and
immunological roles of key mitochondrial metabolism-related genes in cervical
cancer.
Front Oncol. 2025;15:1522910. PubMed Abstract available
BAGHERI Z, Abuei H, Jaafari A, Taki S, et al Inhibition of p16 and NF-kappaB Oncogenic Activity in Human Papillomavirus-Infected
Cervical Cancer Cells: A New Role for Activating Transcription Factor-3.
Yale J Biol Med. 2025;98:21-32. PubMed Abstract available
WOJEWODA B, Korman M, Kamzol W, Jaglarz-Bialy K, et al Knowledge and awareness of cervical cancer and prevention measures among female
students in Poland: a cross-sectional, decade apart study.
J Gynecol Oncol. 2025;36:e23. PubMed Abstract available
OLTHOF EP, Wenzel HHB, van Maaren MC, van der Velden J, et al Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical
cancer with suspicious lymph nodes on imaging: a retrospective cohort study.
J Gynecol Oncol. 2025;36:e16. PubMed Abstract available
LIN C, Xiao N, Chen Q, Liao D, et al Prognostic implications of tumor volume reduction during radiotherapy in locally
advanced cervical cancer: a risk-stratified analysis.
Radiat Oncol. 2025;20:47. PubMed Abstract available
WU T, Wang Y, Cui X, Xue P, et al AI-Based Identification Method for Cervical Transformation Zone Within Digital
Colposcopy: Development and Multicenter Validation Study.
JMIR Cancer. 2025;11:e69672. PubMed Abstract available
VOJTISEK R, Baxa J, Hosek P, Kovarova P, et al Association of long-term treatment outcomes with changes in PET/MRI
characteristics and the type of early treatment response during concurrent
radiochemotherapy in patients with locally advanced cervical cancer.
Strahlenther Onkol. 2025 Mar 31. doi: 10.1007/s00066-025-02389. PubMed Abstract available
WILLIAMS K, Carmona-Gonzalez M Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical
Cancer.
Cureus. 2025;17:e79838. PubMed Abstract available
LIU J, Chen S, Chen J, Liu H, et al Effects of perioperative oxycodone as the sole opioid on immunity within a
multi-modal analgesia framework in patients undergoing cervical cancer surgery: A
randomised controlled trial.
Indian J Anaesth. 2025;69:191-199. PubMed Abstract available
CAO XZ, Zhang YF, Song YW, Yuan L, et al DNA methyltransferase 1/miR-342-3p/Forkhead box M1 signaling axis promotes
self-renewal in cervical cancer stem-like cells in vitro and nude mice models.
World J Stem Cells. 2025;17:99472. PubMed Abstract available
SHEN C, Zhang J, Zhang G, Luo H, et al Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs)
for cervical cancer: A bibliometric study from 2014 to 2024.
Hum Vaccin Immunother. 2025;21:2483031. PubMed Abstract available
JIAO YS, Li C, Xiang Y [Advances of targeting EZH2 in gynecological malignancies].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:236-240. PubMed
CHEN YQ, Huang QM, Hong ML, Zhu YQ, et al [Value of high-risk HPV viral load in cervical cancer screening and triage: a
real world retrospective study based on cervical cancer screening program in
Quanzhou, China].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:193-201. PubMed Abstract available
WU GP, Liu DG, Jin ML [Advances in cytopathology in China over the past ten years: retrospect and
prospect].
Zhonghua Bing Li Xue Za Zhi. 2025;54:341-347. PubMed Abstract available
WANG Y, Xie L, Jin S, Hou Y, et al Activation of TRIM37 by ATF6 and degradation of ACSL4: inhibiting ferroptosis and
propelling cervical cancer progression.
Hereditas. 2025;162:47. PubMed Abstract available
YOU Q, Li L, Liu L An integrated approach of transcriptomics, network pharmacology and molecular
docking uncovers the mechanisms of 5,6,7,4'-tetramethoxyflavone in treating
cervical cancer.
Biochem Biophys Res Commun. 2025;760:151611. PubMed Abstract available
ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al Alternative use of droxidopa for treating cervical cancer: inhibiting
transferase, cell cycle signalling, and transport proteins via multitarget
docking, DFT, MD simulations, and binding free energy studies.
Med Oncol. 2025;42:143. PubMed Abstract available
EL-ZEIN M, Franco EL Evolution and future of cervical cancer screening: from cytology to primary HPV
testing and the impact of vaccination.
Expert Rev Mol Diagn. 2025 Apr 4:1-8. doi: 10.1080/14737159.2025.2486653. PubMed Abstract available
SILFAROHANA R, Waskita KN, Mar'ah NH, Rohman MS, et al Investigating the Potential Synergistic Effects of Turmeric Extract and Black
Rice Bran as Cytotoxic Agents Against HeLa Cells.
Asian Pac J Cancer Prev. 2025;26:1059-1067. PubMed Abstract available
RAMAN RR, Meet S, Tiwari HM, Oswal K, et al Designing and Implementing a Cancer Screening Program for Underserved Tribal
Women in Jharkhand.
Asian Pac J Cancer Prev. 2025;26:977-984. PubMed Abstract available
ALAWADHI E, Albahar S, Tolma E, Longenecker J, et al Disparities in the Uptake of Cervical Cancer Screening in Kuwait: A
Cross-Sectional Analysis of the Nationwide WHO STEPS Survey.
Asian Pac J Cancer Prev. 2025;26:861-868. PubMed Abstract available
HOMSUP P, Pohthipornthawat N, Ariyasriwatana C, Oranratanaphan S, et al Role of Cyclooxygenase-2 (COX-2) Expression as a Prediction of Persistent
Cervical Low Grade Squamous Intraepithelial Lesion (LSIL).
Asian Pac J Cancer Prev. 2025;26:791-797. PubMed Abstract available
CHAWLA L, Rajaram S, Sahoo I, Panta S, et al Counselling to Screening: Honing an Institutional Cervical Cancer Screening
Program.
Asian Pac J Cancer Prev. 2025;26:785-789. PubMed Abstract available
ARAUJO EA, Lima FJL, Cartagenes MDSS, Silva GEB, et al Role of SNHGs in Adverse Prognostic Factors in Cervical Cancer: A Systematic
Review.
Asian Pac J Cancer Prev. 2025;26:735-741. PubMed Abstract available
KONNO Y, Ohnishi S, Minobe S, Nomura E, et al Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients
With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based
Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study
(JORTC-KMP03).
Integr Cancer Ther. 2025;24:15347354251329346. PubMed Abstract available
FU K, Yangzom K, Li L, Wu L, et al Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3:
A 10-Year Retrospective Cohort Study.
Cancer Med. 2025;14:e70825. PubMed Abstract available
AGUS SOMIA IK, Purwanta MLA, Winarti NW, Dwija IBNP, et al Prevalence and risk factors of high-risk HPV and cervical abnormalities in
HIV-positive women in Bali, Indonesia.
BMC Infect Dis. 2025;25:432. PubMed Abstract available
MORENZ A, Ganguly A, Kessler L, Coronado G, et al Asking About Cervical Cancer Screening in National Surveys: Implications for
Health Literacy and Research.
Am J Prev Med. 2025 Mar 26:S0749-3797(25)00103. PubMed Abstract available
MACANDER C, Wang H, Galafassi M, Jones GM, et al Role of Race, Rurality, and Age in Human Papillomavirus Vaccine Initiation among
US Women.
South Med J. 2025;118:206-210. PubMed Abstract available
ACEVEDO-SANCHEZ V, Rodriguez-Hernandez RM, Aguilar-Ruiz SR, Torres-Aguilar H, et al Keratinocyte-derived extracellular vesicles induce macrophage polarization toward
an M1-like phenotype.
Biochem Biophys Res Commun. 2025;758:151659. PubMed Abstract available
LI Z, Zhang X, Li G, Peng J, et al Light scattering imaging modal expansion cytometry for label-free single-cell
analysis with deep learning.
Comput Methods Programs Biomed. 2025;264:108726. PubMed Abstract available
UUSKULA A, Tisler A, DeHovitz J, Murenzi G, et al Prevention and control of HPV-related cancers in people living with HIV.
Lancet HIV. 2025;12:e293-e302. PubMed Abstract available
JIN C, Luo L, Lin H, Hou J, et al HMIL: Hierarchical Multi-Instance Learning for Fine-Grained Whole Slide Image
Classification.
IEEE Trans Med Imaging. 2025;44:1796-1808. PubMed Abstract available
LEE M, Andrieu PIC, Nougaret S, Russo L, et al Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for
Early-Stage Endometrial and Cervical Cancers.
AJR Am J Roentgenol. 2025 Jan 8. doi: 10.2214/AJR.24.32157. PubMed Abstract available
ZHANG W, Song Y, Shi H, Lu B, et al Further confirmation of a highly prognostic grading scheme based upon tumour
budding and cell cluster size in cervical squamous cell carcinoma.
Histopathology. 2025;86:967-978. PubMed Abstract available
KONG L, Xiao X, Wu H, You Y, et al Triage performance of DNA methylation for women with high-risk human
papillomavirus infection.
Oncologist. 2025;30:oyae324. PubMed Abstract available
YI J, Chen J, Cao X, Pi L, et al Development and validation of the competing risk nomogram and risk classification
system for predicting cancer-specific mortality in patients with cervical
adenosquamous carcinoma treated via radical hysterectomy.
Biomol Biomed. 2025;25:1099-1110. PubMed Abstract available
MIZUNO M, Kamio M, Sakihama M, Yanazume S, et al The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in
Self-Collected Urine and Vaginal Samples from Japanese Women.
Gynecol Obstet Invest. 2025;90:143-152. PubMed Abstract available
WANG Y, Tan Y, Yang S, Wei J, et al HLTF/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from
Cervical Precancerous Lesions to Cervical Carcinoma in vitro.
Gynecol Obstet Invest. 2025;90:108-119. PubMed Abstract available
WEXLER C, Maloba M, Mabachi N, Maosa N, et al Availability and Uptake of Cervical Cancer Screening and Treatment Services at 19
Kenyan Health Facilities: A Brief Report.
JCO Glob Oncol. 2025;11:e2400255. PubMed Abstract available
BENNETT LR, Astari P Unpacking cervical cancer stigma in healthcare: lessons learnt from Indonesian
patients and health professionals.
Cult Health Sex. 2025 Apr 11:1-16. doi: 10.1080/13691058.2025.2488036. PubMed Abstract available
MATSUMURA N, Mandai M PMDA regulatory update on approval and revision of the precautions for use of
anticancer drugs; approval of amivantamab plus lazertinib for non-small cell lung
cancer, durvalumab for small cell lung cancer, tislelizumab for esophageal
cancer, tisotuma
Int J Clin Oncol. 2025 Apr 11. doi: 10.1007/s10147-025-02758. PubMed
KUMAR W, Lohia S, Agrawal A, Yadav V, et al A rare case of synchronous cervical squamous cell carcinoma and invasive ductal
carcinoma of breast.
J Cancer Res Ther. 2025;21:281-283. PubMed Abstract available
SARAWAGI R, Sharma DN, Kumar R, Subramani V, et al Positron emission tomography versus computed tomography -guided intracavitary
brachytherapy for locally advanced cervical cancer: A prospective randomized
study.
J Cancer Res Ther. 2025;21:151-155. PubMed Abstract available
GOYAL LD, Garg P, Kankaria A, Kaur N, et al The current status of cervical cancer awareness and HPV Vaccination among rural
women of India: An impediment to the WHO cervical cancer elimination initiative.
J Cancer Res Ther. 2025;21:57-63. PubMed Abstract available
DIAZ-VALLEJO JJ, Lagunes-Baez E, Cordoba-Colorado D, Perez-Vasquez MO, et al Determination of Human Papillomavirus Serotypes in Endocervical Samples from
Patients with Normal Cytology from a Mexican Population by Polymerase Chain
Reaction-restriction Fragment Length Polymorphism.
Indian J Public Health. 2025;69:115-118. PubMed Abstract available
QAMAR J, Maheen M, Mohammad JG Insufficient resources for cervical cancer in Pakistan: a significant burden on
public health.
Ann Med Surg (Lond). 2025;87:1114-1116. PubMed
CHOI W, Shim E The effects of human papillomavirus vaccination in Japan.
Hum Vaccin Immunother. 2025;21:2489301. PubMed Abstract available
CHEN T, Xu Y, Yang K, Du Y, et al Withaferin A combined with ricolinostat: a potent synergistic therapy for
cervical cancer through regulating p53 ubiquitination and acetylation.
Acta Biochim Biophys Sin (Shanghai). 2025 Apr 10. doi: 10.3724/abbs.2025048. PubMed
SEIFU BL, Negussie YM, Asnake AA, Asebe HA, et al Wealth-related inequalities of women's cervical cancer screening in 11
Sub-Saharan African countries: evidence from a pooled decomposition analysis.
Sci Rep. 2025;15:12289. PubMed Abstract available
BANO N, Ahmad S, Gupta D, Raza K, et al FDA-approved Levophed as an alternative multitargeted therapeutic against
cervical cancer transferase, cell cycle, and regulatory proteins.
Comput Biol Med. 2025;191:110163. PubMed Abstract available
JOE TR, Natonie KM, Charley KR, Lee NR, et al Increasing HPV and Cervical Cancer Education Among Native American Communities
and Healthcare Providers.
J Cancer Educ. 2025 Apr 10. doi: 10.1007/s13187-025-02619. PubMed Abstract available
TAUMBERGER N, Friko I, Der VM, Ellis LB, et al Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer
Screening in Ghana: A Study (CarciSCAN) Protocol.
Cancer Control. 2025;32:10732748251330698. PubMed Abstract available
XU Z, Wang M, Gong L, Luo G, et al Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic
cervical cancer: a case report.
Front Oncol. 2025;15:1541760. PubMed Abstract available
MORALES-CAMPOS DY, Adsul P, Liang Y, Donovan E, et al Trusted health system implementation strategies to increase vaccination (TRUE
SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.
BMC Public Health. 2025;25:1331. PubMed Abstract available
NESSA A, Azad AK, Uddin SMN, Khan MAH, et al Cervical cancer screening data from the case-based national electronic registry
in Bangladesh.
BMC Glob Public Health. 2025;3:34. PubMed Abstract available
BAO Q, Tang W, Tang W, Zhu X, et al Identification of immune-related cervical cancer prognostic biomarkers and
construction of prognostic model based on tumor microenvironment.
Eur J Med Res. 2025;30:261. PubMed Abstract available
VAN DER MERWE M, Myburgh K, Garnis C, Towle R, et al Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of
progression, resistance, and emerging therapeutic strategies.
Gene. 2025 Apr 7:149467. doi: 10.1016/j.gene.2025.149467. PubMed Abstract available
ULARNWONG M, Hanamornroongruang S, Ruengkhachorn I, Karnchanabanyong W, et al Diagnostic Accuracy of the Siriraj Portable Digital Cervicography Device Versus
Standard Colposcopy for Detecting CIN2(+) Lesions.
J Med Virol. 2025;97:e70339. PubMed Abstract available
SUN H, Zhang Y, Wang F, Wang Z, et al SORBS3-beta suppresses lymph node metastasis in cervical cancer by promoting the
ubiquitination of beta-catenin.
J Transl Med. 2025;23:406. PubMed Abstract available
XING H, Sun R, Ren J, Wei J, et al Achieving flexible fairness metrics in federated medical imaging.
Nat Commun. 2025;16:3342. PubMed Abstract available
BIZZARRI N, Schivardi G, Di Martino G, Antonacci A, et al Factors associated with bilateral sentinel lymph node mapping failure using
indocyanine green in patients with apparent early-stage cervical cancer: An
Italian retrospective multi-center study.
Eur J Surg Oncol. 2025;51:109981. PubMed Abstract available
AUTHIER CIPOLLA EC, Tourinan MR, Lamonica CB, Bazzi AR, et al [Ectopic ACTH secretion by neuroendocrine carcinoma of the uterine cervix].
Medicina (B Aires). 2025;85:439-444. PubMed Abstract available
NIKOLOULOPOULOS AK Vine copula mixed models for meta-analysis of diagnostic accuracy studies without
a gold standard.
Biometrics. 2025;81:ujaf037. PubMed Abstract available
BIEDERMAN EB, Stump TE, Monahan PO, Katz ML, et al A Randomized Control Trial of Two Interventions Compared to Usual Care for
Increasing Cervical Cancer Screening Among Women Living in the Rural Midwest.
Cancer Epidemiol Biomarkers Prev. 2025 Apr 8. doi: 10.1158/1055-9965.EPI-24-0971 PubMed Abstract available
ZHAO Z, Peng Y, Yang Y, Li S, et al ATP13A2 as a prognostic biomarker and its correlation with immune infiltration in
cervical cancer: A retrospective study.
J Cell Mol Med. 2025;29:e70097. PubMed Abstract available
LIU J, Han B, Hu X, Yuan M, et al Identification of N6-methyladenosine-associated ferroptosis biomarkers in
cervical cancer.
Hereditas. 2025;162:53. PubMed Abstract available
CHABALALA TV, Maimela E, Mashaba RG, Ntimana CB, et al Factors that contribute to women's reluctance to undergo cervical cancer
screening in clinics of Limpopo Province, South Africa.
BMC Public Health. 2025;25:1303. PubMed Abstract available
HU X, Wang Y, Guo H, Guo Y, et al The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential
biological functions in cervical carcinoma.
J Obstet Gynaecol. 2025;45:2463416. PubMed Abstract available
DENG E, Gu Z, Wei H, Liu C, et al Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with
Lymph Node Metastasis: An Analysis Based on the SEER Database.
Reprod Sci. 2025 Apr 7. doi: 10.1007/s43032-025-01856. PubMed Abstract available
JAWOREK H, Bouska O, Kourilova P, Hajduch M, et al High-risk HPV prevalence in the Czech cervical cancer screening population: a
comparison of clinician-collected and self-collected sampling.
Eur J Public Health. 2025 Apr 7:ckaf045. doi: 10.1093. PubMed Abstract available
ZHU ZM, Huo FC, Shi C, Li MT, et al METTL3-mediated m6A modification of PAK6 drives cervical cancer progression
through activating MAPK14.
Int J Biol Macromol. 2025;309. PubMed Abstract available
SHAO D, Yu H, Zhu X Screening and identification analysis of core markers for leukemia and cervical
cancer: Calmodulin 3 as a core target.
Medicine (Baltimore). 2025;104:e41665. PubMed Abstract available
YOUNAS S, Nosheen A, Malik ZI, Hussain N, et al Genetic analysis of HPV-16 L1 gene mutations and computational screening of
therapeutic inhibitors for cervical cancer treatment.
Med Oncol. 2025;42:153. PubMed Abstract available
SOUZA APO, de Lima LA, Ferreira PAB, Dutra RF, et al Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative
Approaches and Tumor Biomarkers.
Curr Top Med Chem. 2025 Apr 4. doi: 10.2174/0115680266366335250314081522. PubMed Abstract available
WU X, Lin K, Gao C, Ni Y, et al miR-627-5p inhibits malignant progression of cervical cancer by targeting
ANGPTL4.
Eur J Histochem. 2025;69. PubMed Abstract available
PANG G, Li Y, Shi Q, Tian J, et al Omics sciences for cervical cancer precision medicine from the perspective of the
tumor immune microenvironment.
Oncol Res. 2025;33:821-836. PubMed Abstract available
PANKAJ S, Rani J, Kumari P, Abhilashi K, et al Efficacy of HPV E6/E7 mRNA assay, HPV DNA test and cytology in detection of high
grade cervical lesions and invasive cancer at a tertiary care center in India.
Malawi Med J. 2024;36:120-127. PubMed Abstract available
HELLFRITSCH J, Panzer M, Wagner S, Nieschke K, et al First Results for the Evaluation of the Cervical Cancer Screening Carried Out in
2021 and 2022 in the Context of the Organized Cancer Screening Program (oKFE):
Part 1 - Primary Screening.
Geburtshilfe Frauenheilkd. 2025;85:417-433. PubMed Abstract available
SUN S, Gong X, Liang Y, Sun Y, et al Evaluating the Implementation of fan-beam CT-guided online adaptive re-planning
in definitive cervical cancer radiotherapy.
Front Oncol. 2025;15:1509619. PubMed Abstract available
GETINET M Oncogenic human papillomavirus infection (HPV 16/18) and associated factors among
women in East Gojjam Zone, NorthWest Ethiopia 2021.
Afr Health Sci. 2024;24:9-19. PubMed Abstract available
ZHANG Y, Li B, Li J, Zhao J, et al NDRG1/2 as a prognostic predictive biomarker of cervical cancer and its
correlation with immune infiltration.
Biomark Med. 2025 Apr 7:1-11. doi: 10.1080/17520363.2025.2483495. PubMed Abstract available
BATUR P, Brant A, McCourt C, Schwarz EB, et al Society of Family Planning Clinical Recommendation: Contraceptive considerations
for individuals with cancer and cancer survivors part 2 - Breast, ovarian,
uterine, and cervical cancer.
Contraception. 2025 Mar 27:110867. doi: 10.1016/j.contraception.2025.110867. PubMed Abstract available
CHEN H, Guo K, Bai Z, Lu L, et al Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus
Agents.
Cancer Med. 2025;14:e70847. PubMed Abstract available
REN J, Xie L, Zhu X, Chen X, et al Resveratrol interrupts Wnt/beta-catenin signalling in cervical cancer by activating
ten-eleven translocation 5-methylcytosine dioxygenase 1.
Cytokine. 2025;190:156930. PubMed Abstract available
MENG X, Song S, Li K, Duan Y, et al Application of CT in predicting lymph node metastasis in cervical cancer and
construction of a preoperative nomogram.
Sci Rep. 2025;15:11674. PubMed Abstract available
MILLET N, McDermott HJ, Munir F, Edwardson CL, et al The feasibility and acceptability of delivering and evaluating a physical
activity intervention (ACCEPTANCE) for cervical cancer survivors.
Pilot Feasibility Stud. 2025;11:42. PubMed Abstract available
CHEN L, Liu W, Wang M, Feng Y, et al Expression of REV7 has prognostic significance in cervical cancer treated with
intensity-modulated radiation therapy.
Discov Oncol. 2025;16:466. PubMed Abstract available
HAITH L, Deaney C, Reesby D, Ellis V, et al A Retrospective Observational Study on the Impact of Digital Strategies to Boost
Cervical Screening Uptake in Primary Care.
Cancer Control. 2025;32:10732748251330705. PubMed Abstract available
AJAH MI, Dibua MEU, Ajah LO, Chigor NV, et al Exploring the role of cervicovaginal microbiota as risk factor for cervical
cancer in Sub-Saharan Africa: a systematic review and meta-analysis : By.
BMC Womens Health. 2025;25:160. PubMed Abstract available
HADDISON EC, Engoung DB, Bodo CB, Njie VM, et al Overcoming HPV vaccine hesitancy: insights from a successful school-based
vaccination campaign in the Saa health district of Cameroon.
BMC Infect Dis. 2025;25:465. PubMed Abstract available
LOPES-NUNES J, Lopes M, Rosado B, Maocha IG, et al Vaginal formulation development: A strategy based on aptamer-guided liposome for
human papillomavirus-induced lesions.
Eur J Pharm Biopharm. 2025;210:114693. PubMed Abstract available
KANDURI M, Subhash S, Putino R, Mahale S, et al IER3: exploring its dual function as an oncogene and tumor suppressor.
Cancer Gene Ther. 2025;32:450-463. PubMed Abstract available
TURPIN A, Tran PL, Encaoua J, Khettab M, et al [Cancer of the cervix management in Reunion Island from 2016 to 2020].
Bull Cancer. 2025;112:396-402. PubMed Abstract available
PETRELLI F, Riboldi V, Bruschieri L, Villa A, et al First-line treatment of locally advanced cervical carcinoma: An updated
systematic review and Bayesian network meta-analysis.
Cancer Treat Rev. 2025;135:102921. PubMed Abstract available
ALQETHAMI A, Alhalal E A theory-based educational intervention to increase mothers' intention to
vaccinate their daughters against human papillomavirus: A randomised controlled
trial.
Patient Educ Couns. 2025;135:108731. PubMed Abstract available
MISZCZYK K, Keczkowska E, Ciebiera M Cervical screening during pregnancy - a review of recommendations.
Ginekol Pol. 2025;96:220-224. PubMed Abstract available
DEMA E, Osman R, Soldan K, Field N, et al Are there any sociodemographic factors associated with non-uptake of HPV
vaccination of girls in high-income countries with school-based vaccination
programmes? A systematic review.
J Epidemiol Community Health. 2025;79:388-396. PubMed Abstract available
WANG B, Zhang Q, Wang L, Su H, et al ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT
signaling pathway through modulation of TYMP.
Naunyn Schmiedebergs Arch Pharmacol. 2025;398:6009-6020. PubMed Abstract available
RAMIREZ AT, Mesher D, Baena A, Salgado Y, et al Impact of knowledge of HPV positivity on cervical cytology performance in latin
america.
J Natl Cancer Inst. 2024 Nov 12:djae283. doi: 10.1093. PubMed Abstract available
BHARTI JN Adenoid basal carcinoma cervix - A rare epithelial neoplasm.
J Cancer Res Ther. 2025;21:226-229. PubMed Abstract available
BUKOWSKI A, Hoyo C, Graff M, Vielot NA, et al Epigenome-wide differential methylation and differential variability as
predictors of high-grade cervical intraepithelial neoplasia (CIN2+).
Am J Epidemiol. 2025;194:1012-1022. PubMed Abstract available
LI S, Tang J, Wang J, Liu X, et al Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to
Thyroid Gland.
Ear Nose Throat J. 2025;104. PubMed Abstract available
RETRACTION: A Meta-Analysis Examining the Impact of Open Surgical Therapy versus
Minimally Invasive Surgery on Wound Infection in Females With Cervical Cancer.
Int Wound J. 2025;22:e70573. PubMed Abstract available
ZHOU D, Hou J, Xi J, Li Y, et al Cost-benefit analysis of p16(INK4a) immunocytology and liquid-based cytology
triage after primary HPV testing for cervical cancer screening in China.
Infect Agent Cancer. 2025;20:26. PubMed Abstract available
TAGHIZADIEH M, Kalantari M, Bakhshali R, Kobravi S, et al To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell
death.
Cancer Cell Int. 2025;25:153. PubMed Abstract available
TIAN M, Qin F, Sun X, Pang H, et al A Hybrid Model-Based Clinicopathological Features and Radiomics Based on
Conventional MRI for Predicting Lymph Node Metastasis and DFS in Cervical Cancer.
J Imaging Inform Med. 2025 Apr 18. doi: 10.1007/s10278-024-01371. PubMed Abstract available
ZHANG N, Ling H, Zhang W, Zhang M, et al A prediction method for radiation proctitis based on SAM-Med2D model.
Sci Rep. 2025;15:13426. PubMed Abstract available
KORKMAZ ASLAN G, Kilinc Isleyen E, Kartal A Associations of eHealth Literacy With Cervical Cancer and Human Papillomavirus
Awareness Among Women in Turkiye: A Cross-sectional Study.
Comput Inform Nurs. 2025 Apr 18. doi: 10.1097/CIN.0000000000001314. PubMed Abstract available
EBISCH RMF, Buijssen C, Visser NCM, Siebers AG, et al The Risk of Developing Cervical Cancer in the Elderly; Who Benefits From
Screening After the Age of 60?
J Low Genit Tract Dis. 2025 Apr 18. doi: 10.1097/LGT.0000000000000893. PubMed Abstract available
XIANG Z, Li Z, Chen X, Fu Y, et al Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent,
or metastatic cervical cancer: a cost-effectiveness analysis.
Front Immunol. 2025;16:1562875. PubMed Abstract available
LIU RC, Ji YM, Huang J, Du YP, et al Charged multivesicular body protein 4C promotes the progression of cervical
cancer through the HPV E6/miR?543 axis.
Oncol Lett. 2025;29:275. PubMed Abstract available
JABBARI A, Najafpour Z, Ourang S, Cheraghi M, et al Developing and validating key performance indicators for breast, cervical, and
colorectal cancer screening programs: a literature review and Delphi survey.
Front Public Health. 2025;13:1491226. PubMed Abstract available
SOLTANIZADEH S, Rosendahl M, Froding LP, Bjorn SF, et al After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of
Fertility-Sparing Surgery for Cervical Cancer.
Semin Reprod Med. 2025 Apr 17. doi: 10.1055/s-0045-1808092. PubMed Abstract available
CHEN CC, Wang S, Yang JM, Huang CH, et al Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through
Combined Inhibition of FAK and PI3K.
Int J Mol Sci. 2025;26:3040. PubMed Abstract available
FLORKEMEIER I, Hotze HL, Heyne AL, Hildebrandt J, et al Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to
Radiotherapy in Cervical Carcinoma.
Int J Mol Sci. 2025;26:2829. PubMed Abstract available
WANG Y, Wang Z, Qu W, Chen F, et al Patterns of Co-infection of HPV52 With Other HPV Genotypes and Their Risks of
Cervical Precancer and Carcinoma.
J Med Virol. 2025;97:e70312. PubMed Abstract available
REDDY R, Gaiwak V, Goda JS, Teni T, et al 'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer
in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis.
Biochem Biophys Rep. 2025;42:101987. PubMed Abstract available
HU M, Ji L, Jin L, Shao M, et al Minimally invasive surgery for cervical cancer.
Oncol Lett. 2025;29:281. PubMed Abstract available
BAWUAH A, Wang VQ, Adeleye K, Ameyaw EK, et al Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A
Multi-Country Cross-Sectional Analysis.
Health Sci Rep. 2025;8:e70663. PubMed Abstract available
MOHAMMED E, Kaba M, Taye G, Assefa M, et al Reasons for not undergoing cervical cancer screening: perspectives from women and
health care providers in Addis Ababa: a qualitative study.
Front Oncol. 2025;15:1456804. PubMed Abstract available
DAI X, Ye X, Ren J, Yang J, et al Construction of the preoperative staging prediction model for cervical cancer
based on deep learning and MRI: a retrospective study.
Front Oncol. 2025;15:1557486. PubMed Abstract available
HUERTA-PADILLA V, Marrero-Rodriguez D, Taniguchi-Ponciano K, Lopez AE, et al Thymopoietin-alpha, -beta, and -gamma Isoforms Increased Expression in Cervical Cancer
Cells.
Can J Infect Dis Med Microbiol. 2025;2025:1668482. PubMed Abstract available
KRISHNAMOORTHY S, Vasudevan S, Muruganantham B, Muthusami S, et al Epinephrine augments the phosphorylation of EGFR and promote the DNA synthesis
and migration of cervical cancer cells.
3 Biotech. 2025;15:125. PubMed Abstract available
LICHTENFELS M, Almeida Lima Nunes R, Mendoza Lopez RV, Alves da Silva C, et al Gastrin-releasing peptide receptor: a promising new biomarker to identify
cervical precursor lesions and cancer.
Rev Bras Ginecol Obstet. 2025;47:e-rbgo4. PubMed Abstract available
LI H, Zhou D, Wang W, Aimaier R, et al Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.
Probiotics Antimicrob Proteins. 2025 Apr 17. doi: 10.1007/s12602-025-10534. PubMed Abstract available
LI C, Ke P Regional differences in the disease burden and attributable risk factors of
female cancers.
Sci Rep. 2025;15:13092. PubMed Abstract available
ZHU JF, Wang YQ, Yang SM, Wang YL, et al Exploring the mechanism of Bruceine D against cervical cancer by network
pharmacology and the effect of Bruceine D on the EGFR pathway.
J Pharm Biomed Anal. 2025;262:116887. PubMed Abstract available
WANG X, Du Q, Mai Q, Zou Q, et al Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in
cervical cancer.
Transl Oncol. 2025;56:102396. PubMed Abstract available
ADEGBOYEGA A, Mudd-Martin G, Schoenberg NE, Dignan M, et al HPV Self-Sampling Promotion Among African American (AA) and Sub-Saharan African
(SAI) Immigrant Women: Adaptation and Usability Testing.
Int J Environ Res Public Health. 2025;22:317. PubMed Abstract available
KARIM MA, Zhang N, Zhao H, Shih YT, et al Trends in Medicare payments within the first year of cervical cancer diagnosis,
2010-2019.
JNCI Cancer Spectr. 2025 Apr 16:pkaf043. doi: 10.1093. PubMed Abstract available
WU M, Zhang K, Li Y, Yu B, et al Endovaginal coil combined with pelvic array coil magnetic resonance imaging for
the preoperative staging of cervical cancer.
Quant Imaging Med Surg. 2025;15:3189-3197. PubMed Abstract available
SHEN L, Wen N, Xia M, Zhang Y, et al Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates
cisplatin?induced apoptosis in human cervical cancer HeLa cells.
Oncol Lett. 2025;29:274. PubMed Abstract available
LIU X, Ren H, Wang A, Liang Z, et al SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1.
Hum Cell. 2025;38:88. PubMed Abstract available
VALENTIN ME, Abdelal Q, Isern S, Ashby T, et al Rapidly progressive pneumonitis days after receiving tisotumab vedotin: a new
antibody-drug conjugate.
BMJ Case Rep. 2025;18:e264150. PubMed Abstract available
MA X, Zhang L, Lu J, Xu P, et al Development and validation of ADC-based nomogram model for predicting the
prognostic factors in preoperative clinical early-stage cervical cancer patients.
Abdom Radiol (NY). 2025 Apr 15. doi: 10.1007/s00261-025-04944. PubMed Abstract available
SASIVIMOLRATTANA T, Liewchalermwong S, Chantratita W, Sensorn I, et al Virome capture sequencing for comprehensive HPV genotyping in cervical samples.
Sci Prog. 2025;108:368504251334515. PubMed Abstract available
COOPER S, Schmidt BM, Jama NA, Ryan J, et al Factors that influence caregivers' and adolescents' views and practices regarding
human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence
synthesis.
Cochrane Database Syst Rev. 2025;4:CD013430. PubMed Abstract available
OWUYE AJ, Adefemi AK, Olumodeji AM, Adedeji MO, et al Comparative Study of Serum Malondialdehyde in Women with Cervical Cancer and
Women with High-Risk Human Papillomavirus Infection at The Lagos State University
Teaching Hospital, Lagos.
West Afr J Med. 2024;41:1120-1128. PubMed Abstract available
BLUM AC, Tessema R, Nussbaum L, Hidalgo C, et al "The problem is not detection, it is treatment": exploring why women needing
pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
BMC Health Serv Res. 2025;25:544. PubMed Abstract available
ZHANG S, Wang J, Zhu L The overtreatment rate, medical cost and psychological affection of see-and-treat
versus three-step approaches in the treatment of cervical intraepithelial
neoplasia: a systematic review and meta-analysis.
BMC Womens Health. 2025;25:179. PubMed Abstract available
CHAUHAN NK, Singh K, Kumar A, Mishra A, et al A hybrid learning network with progressive resizing and PCA for diagnosis of
cervical cancer on WSI slides.
Sci Rep. 2025;15:12801. PubMed Abstract available
MATUSIAK K, Bumbuliene Z "Polish mothers and cervical cancer prophylaxis. What do they know and what
attitude do they have towards HPV vaccination?".
J Pediatr Adolesc Gynecol. 2025 Apr 12:S1083-3188(25)00239. PubMed Abstract available
FAN Y, Liu S, Zhao J, Fu Y, et al Intestinal perforation in recurrent cervical cancer following bevacizumab and
pembrolizumab therapy: A case report.
Medicine (Baltimore). 2025;104:e40473. PubMed Abstract available
WANG Y, Cui W, Chu DM Role of Fascin-1 in cervical cancer metastasis via Wnt/beta-catenin pathway
activation.
Biomol Biomed. 2025 Mar 14. doi: 10.17305/bb.2025.12114. PubMed Abstract available
DEAN A, Eldawy N, Mendonca J, Lobaina D, et al HPV-Related Knowledge and Impact of Patient-Provider Communication on
HPV-Associated Cervical Cancer Awareness and Pap Smear Completion in US Women
Aged 21-65 Years.
Cancers (Basel). 2025;17:1188. PubMed Abstract available
Retraction: "Mir-3150B-3P Inhibits the Proliferation and Invasion of Cervical
Cancer Cells by Targeting Tnfrsf11A".
J Investig Med. 2025 Apr 14:10815589251332430. doi: 10.1177/10815589251332430. PubMed
LI N, Peng E, Liu F Prediction of lymph node metastasis in cervical cancer patients using AdaBoost
machine learning model: analysis of risk factors.
Am J Cancer Res. 2025;15:1158-1173. PubMed Abstract available
HOU Y, Zhang L, Wang H, Wang W, et al Development and validation of a risk prediction model for lymph node metastasis
in stage IA2-IIA1 cervical cancer based on laboratory parameters.
Am J Cancer Res. 2025;15:1081-1095. PubMed Abstract available
LUO M, Liu Y, Lv Y Laparoscopic radical hysterectomy and pelvic lymph node dissection for early
cervical cancer effectively improves surgical efficacy.
Am J Transl Res. 2025;17:2103-2111. PubMed Abstract available
ZHANG M, Wang L, Zhang X, Li C, et al Cervical Cancer Screening Rates Among Chinese Women - China, 2023-2024.
China CDC Wkly. 2025;7:321-326. PubMed Abstract available
GAO X, Liu G, Zhao Z, Tang Y, et al Arsenic enhances cervical cancer cell radiosensitivity by suppressing the DNA
damage repair pathway.
Transl Cancer Res. 2025;14:2078-2094. PubMed Abstract available
WANG Y, Wang M, Zhu L The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer
patients after surgery.
J Gynecol Oncol. 2025 Apr 8. doi: 10.3802/jgo.2025. PubMed Abstract available
YUAN L, Wen B, Li X, Lei H, et al A Chinese prospective cohort research developed and validated a risk prediction
model for patients with cervical cancer.
Cancer Cell Int. 2025;25:142. PubMed Abstract available
DE OLIVEIRA CM, Rangeiro R, Osman N, Baker E, et al Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer
screening study in Mozambique.
Infect Agent Cancer. 2025;20:24. PubMed Abstract available
XUE P, Dang L, Kong LH, Tang HP, et al Deep learning enabled liquid-based cytology model for cervical precancer and
cancer detection.
Nat Commun. 2025;16:3506. PubMed Abstract available
DOBROSSY L [Calvary of cytology-based cervical screening in Hungary].
Orv Hetil. 2025;166:578-587. PubMed
DOMINIK P, Sonja MK, Robert J, Marcin P, et al Effect of vaccination against HPV in the HPV-positive patients not covered by
primary prevention on the disappearance of infection.
Sci Rep. 2025;15:12642. PubMed Abstract available
SU L, Xu R, Ren Y, Zhao S, et al 5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune
cell infiltration.
J Int Med Res. 2025;53:3000605251328301. PubMed Abstract available
YUKSEL GH, Ozaydin AN Assessment of Health Beliefs and Motivations for Cervical Cancer Screening.
Healthcare (Basel). 2025;13:804. PubMed Abstract available
AGNILA DRL, Jain R, Diaz MJ, Hudlock TR, et al TCR CDR3 chemical complementarity to HPV epitopes is associated with a better
outcome for cervical cancer.
Mamm Genome. 2025 Apr 11. doi: 10.1007/s00335-025-10127. PubMed Abstract available
RANASINGHE V, McMillan N Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical
cancer.
Crit Rev Oncol Hematol. 2025;211:104721. PubMed Abstract available
MANJILI DA, Babaei FN, Younesirad T, Ghadir S, et al Dysregulated circular RNA and long non-coding RNA-Mediated regulatory competing
endogenous RNA networks (ceRNETs) in ovarian and cervical cancers: A non-coding
RNA-Mediated mechanism of chemotherapeutic resistance with new emerging clinical
capacities
Arch Biochem Biophys. 2025;768:110389. PubMed Abstract available
MALEK M, Moayeri M, Akhavan S, Hasani SS, et al Advanced MRI prediction model for anatomical site identification in uterine
carcinoma: enhancing diagnostic accuracy.
Clin Radiol. 2025;84:106852. PubMed Abstract available
KEUNG MHT, Mehta N, Lynn E, Pineda E, et al Clinical validation of the Roche cobas HPV test on the Roche cobas 6800 system
for the purpose of cervical screening and qualification as a second-generation
comparator test.
J Virol Methods. 2025;335:115145. PubMed Abstract available
GRAY P, Wang J, Nordqvist Kleppe S, Elfstrom KM, et al Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus
Prevalence.
J Infect Dis. 2025;231:e638-e649. PubMed Abstract available
PORTER VL, Ng M, O'Neill K, MacLennan S, et al Rearrangements of viral and human genomes at human papillomavirus integration
events and their allele-specific impacts on cancer genome regulation.
Genome Res. 2025;35:653-670. PubMed Abstract available
NAICKER N, Osman F, Naidoo K, Bodley N, et al High burden of human papillomavirus and premalignant cervical lesions among women
starting HIV treatment in KwaZulu-Natal, South Africa.
Sex Transm Infect. 2025;101:187-190. PubMed Abstract available
HIDAYATULLAH A, Widiastuti D, Putra WE, Rifa'i M, et al Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of
Bioactive Compounds from Various Indonesian Medicinal Plants as Potential
Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer
Development.
Trop Life Sci Res. 2025;36:1-24. PubMed Abstract available
JAREEMIT N, Kolaka W, Tiyayon J, Tangjitgamol S, et al Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a
multicenter retrospective cohort study from the Thai Gynecologic Cancer Society
research group.
J Gynecol Oncol. 2025 Apr 7. doi: 10.3802/jgo.2025. PubMed Abstract available
SVENSGAARD SNH, Tranberg M, Andersen B, Petersen LK, et al Improving cervical cancer screening participation by introducing HPV vaginal
self-sampling to women living with HIV in Denmark- a pilot study.
BMC Womens Health. 2025;25:202. PubMed Abstract available
CSANADI M, Filipi K, Ylli A, Dedja B, et al Barriers of organized cervical cancer screening in Albania and Montenegro.
BMC Public Health. 2025;25:1533. PubMed Abstract available
TONG TRS Cervical Cancer Screening by Human Papillomavirus Testing of Vulvar Swabs.
Arch Pathol Lab Med. 2025;149:395. PubMed
ANG JX, Tay SK Comparison of Clinical Efficacy of Liquid-Based Cytology and High-Risk Human
Papillomavirus Testing With Partial Genotyping in Cervical Screening of Women
Below 30 Years Old.
Cancer Control. 2025;32:10732748251336414. PubMed Abstract available
WANG Z, Cheng L, Li G, Cheng H, et al Epithelial and macrophage cell interaction in cervical cancer through single-cell
RNA-sequencing and spatial analysis.
Front Immunol. 2025;16:1537785. PubMed Abstract available
MADSEN KG, Mosgaard JS, Oshosen M, Swai P, et al Barriers and facilitators for implementation of HPV-based cervical cancer
screening in Tanzania: a qualitative study among healthcare providers,
stakeholders, and Tanzanian women.
Glob Health Action. 2025;18:2491852. PubMed Abstract available
MIAZGA W, Tatara T, Gujski M, Pinkas J, et al Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention.
Med Sci Monit. 2025;31:e947173. PubMed Abstract available
AKIS S, Kabaca C, Purut YE, Keles E, et al The persistence of HPV type-specific infections in patients following colposcopic
examination: An observational study.
J Obstet Gynaecol Res. 2025;51:e16301. PubMed Abstract available
CHAN-ON W, Turinthorn M, Chaiwongkot A, Techawiwattanaboon T, et al ANGPTL4 suppresses progression and improves cisplatin sensitivity in cervical
cancer.
Sci Rep. 2025;15:14217. PubMed Abstract available
INOMATA Y, Kodama K, Maenohara S, Yagi H, et al Retrospective analysis of treatment and prognosis for clear cell carcinoma of the
uterine cervix: 15-year experience at a single institution.
J Obstet Gynaecol Res. 2025;51:e16300. PubMed Abstract available
HOMAEI SHANDIZ F, Arastouei S, Hosseini S, Prasad Giri I, et al Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase
II Non-Randomized Trial on Safety and Efficacy.
Cancer Invest. 2025 Apr 23:1-13. doi: 10.1080/07357907.2025.2493238. PubMed Abstract available
HAKIM RU, Amin T, Ul Islam SMB Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global
Epidemiology to Innovative Therapies and Prevention Strategies.
Cancer Control. 2025;32:10732748251336415. PubMed Abstract available
NEDOVIC VUKOVIC M, Barjaktarovic Labovic S, Jaksic M, Vuckovic L, et al Cervical cancer mortality trend in Montenegro-1990-2018.
Eur J Public Health. 2025 Apr 23:ckaf059. doi: 10.1093. PubMed Abstract available
AVILA-AGUERO ML, Ospina-Henao S, Brenes-Chacon H, Espinal-Tejada C, et al Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer:
Challenges and Opportunities.
Vaccines (Basel). 2025;13:297. PubMed Abstract available
SANTOS MAPD, Macedo HKS, Bezerra HS, Medeiros AA, et al Access to pap smear among black women compared to other racial/ethnic groups: a
systematic review with meta-analysis.
Cien Saude Colet. 2025;30:e01852023. PubMed Abstract available
YAMADA Y, Okuhara T, Yokota R, Furukawa E, et al Evaluating the understandability and actionability of Japanese human
papillomavirus vaccination educational materials on cervical cancer.
Health Promot Int. 2025;40:daaf034. PubMed Abstract available
YADAGIRI U, Shaik R, Kolure R, Fatima T, et al Immunotherapeutics in Clinical Trials for Cervical Cancer.
Cancer Biother Radiopharm. 2025 Apr 22. doi: 10.1089/cbr.2025.0031. PubMed Abstract available
WALL JA, Bratches RW, Barton WC, Boitano TK, et al Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and
Why?
J Palliat Med. 2025 Apr 23. doi: 10.1089/jpm.2024.0344. PubMed Abstract available
HUANG Q, Su W, Li S, Lin Y, et al A bibliometric analysis of artificial intelligence applied to cervical cancer.
Front Med (Lausanne). 2025;12:1562818. PubMed Abstract available
YANG Y, Zhu X, Sun D, Fan J, et al Lnc-CNNM3-DT as a protective factor in cervical cancer: regulation of LIAS
expression and intracellular copper levels.
Front Oncol. 2025;15:1571788. PubMed Abstract available
CHEN Z, Zhao B The role of tumor-associated macrophages in HPV induced cervical cancer.
Front Immunol. 2025;16:1586806. PubMed Abstract available
ZENG J, Yin R Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized
strategies and emerging therapies.
Front Immunol. 2025;16:1567296. PubMed
ZHANG H, Zhou Z, Wang J, Wang S, et al Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a
real-world pharmacovigilance study using the FAERS database.
Front Immunol. 2025;16:1582050. PubMed Abstract available
MORITA C, Fujii Y, Maemura S, Yasuda T, et al Late Bladder Rupture and Strangulated Ileus Following Radical Hysterectomy and
Radiation Therapy for Cervical Cancer.
Cureus. 2025;17:e81016. PubMed Abstract available
Statement of Retraction: The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p
(miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer
through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated
kinase (ERK)
Bioengineered. 2025;16:2496006. PubMed
WANG Y, Ji H, Yang T, Liu Y, et al HSP90 regulates dCK stability and inhibits ionizing radiation-induced ferroptosis
in cervical cancer cells.
Cell Death Discov. 2025;11:191. PubMed Abstract available
HERZIG VAN WEES S, Bakare AA, Akinsola KO, Salako J, et al Building HPV vaccine confidence through codesigned interventions with and for
healthcare workers in Nigeria: protocol for a pilot cluster randomised controlled
trial.
BMJ Open. 2025;15:e098308. PubMed Abstract available
JIN G, Wang J Both complete response and long-term survival after combination therapy with
toripalimab in a patient with meta-oligometastases cervical cancer: a case
report.
Front Immunol. 2025;16:1542795. PubMed Abstract available
NING L, Li X, Xu Y, Si Y, et al Immunogenic cell death genes in single-cell and transcriptome analyses
perspectives from a prognostic model of cervical cancer.
Front Genet. 2025;16:1532523. PubMed Abstract available
JOHN-OLABODE SO, Udenze IC, Adejimi AA, Ajie O, et al Association between tumour necrosis factor-a polymorphism and cervical cancer in
Lagos State, Nigeria.
Ecancermedicalscience. 2025;19:1845. PubMed Abstract available
WANG B, Li L, Wu Z, Qian X, et al Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer
tumorigenesis via the miR-195-5p/IKBKB axis.
Acta Biochim Biophys Sin (Shanghai). 2025 Apr 22. doi: 10.3724/abbs.2025032. PubMed Abstract available
HU Y, Cui M Meta-analysis of the diagnostic value of SOX1 methylation in different types of
cervical cancer.
World J Surg Oncol. 2025;23:147. PubMed Abstract available
SHABANPOUR M, Taherkhani S, Shoja Z, Eftekhari M, et al Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in
cervical samples from Tehran, Iran.
Sci Rep. 2025;15:13736. PubMed Abstract available
ZHANG W, Zhao J, Fan X, Chen S, et al Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the
SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in
cervical cancer.
Cell Death Dis. 2025;16:324. PubMed Abstract available
LU S, Yang H, Mao P, Chen G, et al Vaginal stump rupture due to sexual activity leading to small intestine vaginal
hernia and intestinal necrosis in a woman after cervical cancer surgery: A case
report.
Medicine (Baltimore). 2025;104:e41788. PubMed Abstract available
YASUDA M, Katoh T, Miyama Y, Honma T, et al Histological classification of uterine cervical adenocarcinomas: Its alteration
and current status.
J Obstet Gynaecol Res. 2025;51:e16287. PubMed Abstract available
TAGUCHI T, Yokoyama M, Fujita T, Tanba S, et al Utility of circulating human papillomavirus DNA as a biomarker for detection and
prognosis of cervical cancer in Japanese patients.
Int J Clin Oncol. 2025 Apr 21. doi: 10.1007/s10147-025-02762. PubMed Abstract available
KRISHNA A, N V, Shada F, Ms P, et al Pre-treatment blood parameters as an economical predictive marker for predicting
treatment response in locally advanced cervical cancer.
F1000Res. 2025;14:118. PubMed Abstract available
WANG F, Hengudomsub P, Chantamit-O-Pas C Factors related to stigma among patients with cervical cancer having chemotherapy
after surgery in China: A cross-sectional study.
Belitung Nurs J. 2025;11:194-204. PubMed Abstract available
HOSSEINI SF, Jalali Nadoushan M, Fekrirad Z, Rasooli I, et al Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma
Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.
Anal Cell Pathol (Amst). 2025;2025:1931119. PubMed Abstract available
LIU ZP, Liu SH, Zhao H, Ruan FY, et al Pathologically Complete Response to Camrelizumab and Apatinib in Advanced
Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report.
Case Rep Oncol. 2025;18:480-492. PubMed Abstract available
ZHAO X, Hou S, Hao R, Zang Y, et al Prognostic significance of circulating tumor DNA detection and quantification in
cervical cancer: a systematic review and meta-analysis.
Front Oncol. 2025;15:1566750. PubMed Abstract available
LIAO J, Moshoeshoe R, Holmes MD, Subramanian SV, et al Effect of girls' education on cancer awareness and screening in a natural
experiment in Lesotho.
Nat Commun. 2025;16:3737. PubMed Abstract available
ALHUDHUD M, Maqsood S, Hussein ME, Shaheen R, et al Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear.
BMC Womens Health. 2025;25:198. PubMed Abstract available
LU M, Luo X, Bu Q, Li P, et al Association between low-grade cervical cytology and histological cervical
intraepithelial neoplasia concurrent vaginal intraepithelial neoplasia among
outpatient colposcopy: A retrospective study.
J Obstet Gynaecol Res. 2025;51:e16289. PubMed Abstract available
QU T, Zeng G, Yang J, Tang K, et al Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in
patients with cervical cancer: a systematic review and meta-analysis.
Jpn J Clin Oncol. 2025 Apr 20:hyaf063. doi: 10.1093. PubMed Abstract available
LIAO J, Deng S, Shi B, Wang M, et al HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in
cervical cancer.
Virol J. 2025;22:109. PubMed Abstract available
MADHUKARAN S, Fomina YY, Mahendroo M Cervical function in pregnancy and disease: new insights from single-cell
analysis.
Am J Obstet Gynecol. 2025;232. PubMed Abstract available
HUNSBERGER KS, Kapp DS, Chan JK, Irwin CM, et al Suicide rates of cervical cancer patients in the United States - Who is most at
risk? A retrospective study of 69,493 patients.
J Cancer Policy. 2025;44:100586. PubMed Abstract available
CHEN B, Gao J, Sun H, Chen Z, et al Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables
accurate diagnosis of cervical cancer: from molecule to cell to tissue level.
Crit Rev Oncol Hematol. 2025 Apr 17:104736. PubMed Abstract available
YIN Q, Sun B, Qi X, Wu C, et al Anticancer activity of Momordica charantia-derived extracellular vesicle-like
particle against cervical cancer.
Tissue Cell. 2025;95:102897. PubMed Abstract available
SUN H, Liang Z, Zang Y, Liu S, et al Transcriptome analysis reveals possible antitumor mechanism of intracellular
polysaccharide from Phaeodactylum tricornutum on cervical cancer HeLa cells.
Chem Biodivers. 2025 Apr 19:e202402779. doi: 10.1002/cbdv.202402779. PubMed Abstract available
BAUTISTA-GONZALEZ E, Quintero Leyra A, Munoz Rocha TV, Reyes-Garcia HT, et al Assessing disparities in cancer resources distribution in Mexico.
BMC Health Serv Res. 2025;25:564. PubMed Abstract available
EINARSON TA, Musana E, Balonde J, Lorentzen KB, et al Human papillomavirus awareness, vaccination rate, and sociodemographic covariates
of vaccination status in a low-income country: A cross-sectional study in the
rural Busoga region of Uganda.
Vaccine. 2025;53:127089. PubMed Abstract available
DAVIDSON N, Fisher J "If I know about it of course I would give my son and daughter", barriers to and
enablers of accessing human papillomavirus vaccination among women from refugee
and asylum-seeking backgrounds resettling in Melbourne, Australia - A qualitative
study.
Vaccine. 2025;53:127064. PubMed Abstract available
TIMOSHENKO O, Kugaevskaya E, Gureeva T, Morozevich G, et al Isoxazolyl steroid blocks the Shh signaling pathway and the expression of MMP-2
and MMP-9 in cervical carcinoma cell lines.
Steroids. 2025;217:109599. PubMed Abstract available
PENG Q, Fan P, Wang X, Tao F, et al The impact of plan complexity on dose delivery deviations resulting from
multileaf collimator positioning errors in volumetric modulated arc therapy.
Br J Radiol. 2025;98:785-792. PubMed Abstract available
HARINATH L, Elishaev E, Ye Y, Matsko J, et al Diagnostic performance of the hologic genius digital diagnostics system for
low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests.
J Am Soc Cytopathol. 2025;14:199-207. PubMed Abstract available
SMALL C, Ortiz S, Bedi M, Joyner M, et al How do you do it?: Gynecologic brachytherapy best practices at high volume
institutions within the United States and Canada.
Brachytherapy. 2025;24:365-370. PubMed Abstract available
TANG X, Yang B, Bian W, Li K, et al A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral
Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous
Cell Carcinoma.
Ann Surg Oncol. 2025;32:3449-3457. PubMed Abstract available
LONG X, Ma X, Xiao W, Lv J, et al Clinicopathologic and Genomic Features of Invasive Stratified Mucin-producing
Carcinoma of the Uterine Cervix Coexisting With High-grade Squamous
Intraepithelial Lesion.
Int J Gynecol Pathol. 2025;44:268-273. PubMed Abstract available
NGUYEN DT, Waring D, Wan KM, Loo C, et al Superficial and Invasive Spread of High-grade Squamous Intraepithelial Lesion and
Squamous Cell Carcinoma: A Case Report.
Int J Gynecol Pathol. 2025;44:265-267. PubMed Abstract available
BEN-MUSSA A, Shah R, Rajendran S, McCluggage WG, et al A Population-based Study Investigating the Incidence of Human
Papillomavirus-Associated and Human Papillomavirus-Independent Cervical
Adenocarcinomas.
Int J Gynecol Pathol. 2025;44:249-254. PubMed Abstract available
VON KNEBEL DOEBERITZ M p16INK4a/Ki67 Dual-Staining Immunocytochemistry to Refer Women Infected by
High-Risk Human Papillomavirus for Colposcopy.
Acta Cytol. 2025;69:16-25. PubMed Abstract available
SUNDQVIST A, Hellsten C, Strander B, Lindh M, et al Self-collected vaginal HPV samples for long-term non-attendees in the Swedish
organized cervical cancer screening program.
Acta Obstet Gynecol Scand. 2025 Apr 7. doi: 10.1111/aogs.15112. PubMed Abstract available
KAMIJO K, Miyamoto T, Oshima S, Asaka S, et al Extensive Pathologic Invasion and Prognostic Implication of Gastric-Type Cervical
Adenocarcinoma: A Comparative Analysis With Human Papillomavirus-Associated
Adenocarcinoma.
Am J Surg Pathol. 2025;49:471-480. PubMed Abstract available
WILLIAMS GA 2ND, Wu AA, Eugene HC, Tsai YC, et al Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated
Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
Am J Surg Pathol. 2025 Jan 31. doi: 10.1097/PAS.0000000000002367. PubMed Abstract available
GERHARD R, Colmenarez CR, Selle C, Hammer GP, et al Digital Cytology Combined With Artificial Intelligence Compared to Conventional
Microscopy for Anal Cytology: A Preliminary Study.
Cytopathology. 2025;36:250-258. PubMed Abstract available
ASSUNCAO LD, Discacciati MG, da Silva AG, Yoshida A, et al Clinical Performance of a Liquid Preservation Medium for Cervicovaginal Samples
in DNA-HPV Testing and Liquid-Based Cytology for Cervical Cancer Screening.
Cytopathology. 2025 Apr 23. doi: 10.1111/cyt.13495. PubMed Abstract available
LIN YS, Athanasatos P Evaluating the Cytomorphologic Features of Cervical Adenosquamous Carcinoma.
Diagn Cytopathol. 2025;53:256-261. PubMed Abstract available
ONAL C, Elmali A, Demirhan B, Guler OC, et al Letter comments on: "Induction chemotherapy followed by chemoradiation in locally
advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial".
Eur J Cancer. 2025 Apr 22:115448. doi: 10.1016/j.ejca.2025.115448. PubMed
AYNAUD O, Huynh B, Bergeron C Should men whose female partners have cervical high grade intraepithelial lesion
(HSIL) be screened?
Eur J Obstet Gynecol Reprod Biol. 2025;308:257-260. PubMed Abstract available
HAUGE E, Gustafson LW, Tranberg M, Bor P, et al Risk of cervical stenosis after cervical excision in postmenopausal patients.
Eur J Obstet Gynecol Reprod Biol. 2025;308:208-213. PubMed Abstract available
YUE X, Duan Y, Guo D, Wang Y, et al Diagnostic accuracy of available methylation assays in advanced cervical
intraepithelial neoplasia from high-risk HPV-positive women: A systematic review
and network meta-analysis.
Eur J Obstet Gynecol Reprod Biol. 2025;308:54-65. PubMed Abstract available
WOLF B, Trantaki DS, Horn LC, Aktas B, et al Preoperative conization in cervical cancer patients undergoing open abdominal
radical hysterectomy: Results from a propensity-score matched study.
Gynecol Oncol. 2025;196:69-77. PubMed Abstract available
LORUSSO D, Oaknin A, Borges GS, Damian F, et al Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2
clinical trial.
Gynecol Oncol. 2025;196:28-35. PubMed Abstract available
VELASQUEZ J, Mohammed-Norgan M, Scheiber A, Chalif J, et al Cross-language insights: Comparing Spanish and English-language cervical cancer
content on TikTok.
Gynecol Oncol. 2025;194:131-136. PubMed Abstract available
BORCINOVA M, Kohler C, Nemejcova K, Zapardiel I, et al Preoperative tumour size assessment in patients with early-stage cervical cancer:
Final results of the SENTIX study.
Gynecol Oncol. 2025;196:160-167. PubMed Abstract available
FRIEDMAN EL, Guo XM, Furey KB, Lee AJ, et al Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical
cancer surgery.
Gynecol Oncol. 2025;196:182-191. PubMed Abstract available
LEATH CA 3RD, Deng W, Mell LK, Richardson DL, et al Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally
advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III
randomized trial.
Gynecol Oncol. 2025;195:122-133. PubMed Abstract available
ZHANG Z, Shi H, Shao Y, Lu B, et al Clinicopathologic and molecular characterization of primitive neuroectodermal
tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
Hum Pathol. 2025;157:105769. PubMed Abstract available
HARPER DM, Paczos T, Ridder R, Huh WK, et al p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical
precancerous lesions.
Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353. PubMed Abstract available
FUSEINI NM, El Joueidi S, Montgomery T, Lemrabott E, et al Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot
program to inform development of Mauritania's national cervical cancer prevention
program.
Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145. PubMed
SHANG X, Kong L, You Y, Wu H, et al Cytologic DNA methylation for managing minimally abnormal cervical cancer
screening results.
Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167. PubMed Abstract available
BIZZARRI N, Kyrgiou M, De Vincenzo R, Zapardiel I, et al Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society
of Gynecological Oncology (ESGO) prevention committee opinion.
Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120. PubMed Abstract available
MUNGO C, Omoto J, Ogollah C, Owaya A, et al Safety and adherence to self-administered intravaginal 5-fluorouracil cream
following cervical intraepithelial neoplasia (CIN) 2/3 treatment among
HIV-positive women in Kenya: A phase 1 clinical trial.
Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093. PubMed Abstract available
MORICE P, Gouy S, Plante M, Abu-Rustum N, et al Neoadjuvant chemotherapy in stage IB2 to IB3 cervical cancer: because we can or
because we must?
Int J Gynecol Cancer. 2025 Mar 14:101770. doi: 10.1016/j.ijgc.2025.101770. PubMed
LIMA WAL, Gouveia MC, Oliveira LCM, Scaranti M, et al Revolutionizing first-line cervical cancer treatment: bevacizumab, immunotherapy,
and emerging insights.
Int J Gynecol Cancer. 2025 Jan 28:101661. doi: 10.1016/j.ijgc.2025.101661. PubMed
LIAO J, Xu T, Zhou J, Xiao N, et al The impact of chemotherapy on survival in patients aged >/=65 years with
locoregionally cervical cancer who undergo radiotherapy: a Surveillance,
Epidemiology, and End Results database analysis.
Int J Gynecol Cancer. 2025 Mar 3:101747. doi: 10.1016/j.ijgc.2025.101747. PubMed Abstract available
LEITAO MM JR, Bixel KL, Chase DM, Quick A, et al ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for
early-stage cervical cancer.
Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760. PubMed Abstract available
GAO H, Wu H, Zhang Y, Li X, et al Long-term survival in patients with para-aortic metastatic cervical cancer
receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a
single-center experience.
Int J Gynecol Cancer. 2024;34:1536-1546. PubMed Abstract available
GUO XM, Roman LD, Matsuo K Considerations for route of hysterectomy in low-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1481. PubMed
MATSUO K, Shimada M, Matsuzaki S, Machida H, et al Assessment of postoperative therapy de-escalation for early-stage,
intermediate-risk cervical cancer.
Int J Gynecol Cancer. 2024;34:1349-1358. PubMed Abstract available
BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set
up for the LASH trial.
Int J Gynecol Cancer. 2024;34:1805-1808. PubMed Abstract available
CHEN M, Han L, Wang Y, Chen Y, et al Association between Silva pattern-based classification and endocervical
adenocarcinoma: a systematic review and meta-analysis.
Int J Gynecol Cancer. 2024;34:1704-1710. PubMed Abstract available
CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical
excision procedure (LEEP) specimens.
Int J Gynecol Cancer. 2024;34:1698-1703. PubMed Abstract available
MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al Comparing visual inspection with acetic acid, with and without Lugol's Iodine for
triage of HPV self-sample positive women in Ethiopia: a randomized controlled
trial.
Int J Gynecol Cancer. 2024;34:1691-1697. PubMed Abstract available
LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al Are we making progress in curing advanced cervical cancer-again?
Int J Gynecol Cancer. 2024;34:1940-1945. PubMed Abstract available
GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al Para-aortic lymph node recurrence in surgically treated early-stage cervical
cancer without para-aortic lymph node surgical staging.
Int J Gynecol Cancer. 2024;34:1867-1873. PubMed Abstract available
PAN TL, Pareja R, Chiva L, Rodriguez J, et al Accuracy of pre-operative tumor size assessment compared to final pathology and
frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical
cancer.
Int J Gynecol Cancer. 2024;34:1861-1866. PubMed Abstract available
SALANI R, McCormack M, Kim YM, Ghamande S, et al A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab
plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer
(SKYSCRAPER-04).
Int J Gynecol Cancer. 2024;34:1140-1148. PubMed Abstract available
TESFAI FM, Yongue G, Chandrasekaran D, Francis N, et al Methods of surgical quality assurance in cervical and endometrial cancer trials:
a systematic review and meta-analysis.
Int J Gynecol Cancer. 2025;35:100018. PubMed Abstract available
PAVONE M, Baby B, Carles E, Innocenzi C, et al Critical view of safety assessment in sentinel node dissection for endometrial
and cervical cancer: artificial intelligence to enhance surgical safety and lymph
node detection (LYSE study).
Int J Gynecol Cancer. 2025;35:101789. PubMed Abstract available
WANG G, Chen Y, Wang Z, Zeng Z, et al A prospective single-arm study of daily online adaptive radiotherapy for cervical
cancer with reduced PTV margin: acute toxicity and dosimetric outcomes.
Int J Radiat Oncol Biol Phys. 2025 Apr 1:S0360-3016(25)00309. PubMed Abstract available
SUN DS, Gong X, Cheng S, Cao R, et al Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer
Using Artificial Intelligence.
Int J Radiat Oncol Biol Phys. 2025 Apr 17:S0360-3016(25)00379. PubMed Abstract available
WANG V, Lykken JM, Tiro JA, Perkins RB, et al Guideline-Concordant Surveillance After Treatment for High-Grade Cervical
Dysplasia.
Obstet Gynecol. 2025;145:461-468. PubMed Abstract available
TAGHADOS Z, Azimifar Z, Monsefi M, Jahromi MA, et al CausalCervixNet: convolutional neural networks with causal insight (CICNN) in
cervical cancer cell classification-leveraging deep learning models for enhanced
diagnostic accuracy.
BMC Cancer. 2025;25:607. PubMed Abstract available
WEN K, Wang L, Su H, Yu L, et al Development of a m6A- and ferroptosis-related LncRNA signature for forecasting
prognosis and treatment response in cervical cancer.
BMC Cancer. 2025;25:580. PubMed Abstract available
GE Y, Wu F, Zhang Y, Wang X, et al Prevalence of HPV infection and cervical lesions among women with pelvic organ
prolapse and implications for preoperative evaluation.
BMC Cancer. 2025;25:624. PubMed Abstract available
ZHANG C, Chen L 6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
BMC Cancer. 2025;25:719. PubMed Abstract available
XAVIER SP, Galvao ND, das Neves MAB, da Silva KM, et al Nomogram model for predicting the long-term prognosis of cervical cancer
patients: a population-based study in Mato Grosso, Brazil.
BMC Cancer. 2025;25:684. PubMed Abstract available
KHIARI H, Abdelfatteh YB, Mahjoub N, Mekni K, et al Trends and projections in cervical cancer incidence in northern Tunisia
(1994-2040).
BMC Cancer. 2025;25:739. PubMed Abstract available
BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al Findings from a qualitative analysis: Social media influencers of color as
trusted messengers of HPV vaccination messages.
PLoS One. 2025;20:e0319160. PubMed Abstract available
MAFI S, Theuillon F, Meyer S, Woillard JB, et al Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk
HPV genotyping in cervical samples.
PLoS One. 2025;20:e0320978. PubMed Abstract available
AVILA E, Hernandez-Monterde LD, Cedro-Tanda A, Lizardi-Aguilera TM, et al Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell
line.
PLoS One. 2025;20:e0319812. PubMed Abstract available
WANG G, Jia C, Wang D, Liang L, et al Scutellaria Barbata inhibits epithelial-mesenchymal transformation through
PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting
apoptosis of Cervical Cancer cells.
PLoS One. 2025;20:e0321556. PubMed Abstract available
ABATE A, Munshea A, Nibret E, Bezabih B, et al Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma
virus in Bahir Dar, Amhara Regional State, Ethiopia.
PLoS One. 2025;20:e0321076. PubMed Abstract available
BAASLAND I, Bjorge T, Engesaeter B, Trope A, et al Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and
treatment.
PLoS One. 2025;20:e0320739. PubMed Abstract available
MELAKU A, Abebe SN, Haile S Utilization of screening services on cervical cancer and associated factors among
female health workers in Addis Ababa, Ethiopia.
PLoS One. 2025;20:e0321662. PubMed Abstract available
